Additionally, NHE1 inhibition or depletion reversed cisplatin resistance in breast cancer cells, doxorubicin resistance in human colon cancer cells [69, 80, 82], and caused growth arrest, lowering of pHi and increased responsiveness to cell death inducers in cholangiocarcinoma cells [74, 83]. Here, SLC9A1 is linked to breast carcinoma.